Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/1999
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999US5972352 Cloning of mite allergens
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999CA2057536C Cloning and expression of borrelia lipoproteins
10/26/1999CA2011378C Achromobacter protease i gene and gene product thereof
10/26/1999CA1340805C Nucleotide sequence incoding plant ribosome inactivating protein
10/23/1999CA2268382A1 Overproduction of riboflavin in yeast
10/21/1999WO1999053310A1 Antigen
10/21/1999WO1999053304A1 Method for electroelution of a biological sample and implementing device
10/21/1999WO1999053295A1 Assays for the detection of microtubule depolymerization inhibitors
10/21/1999WO1999053092A1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
10/21/1999WO1999053080A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells
10/21/1999WO1999053079A1 Regulable gene expression in gram-positive bacteria
10/21/1999WO1999053078A2 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999WO1999053077A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999WO1999053075A2 Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants
10/21/1999WO1999053074A1 Enzyme derived from thermophilic organisms that functions as a chromosomal replicase, and preparation and uses thereof
10/21/1999WO1999053069A2 Cell cycle regulatory proteins cdc2 and pitslre from plants
10/21/1999WO1999053063A1 PEPTIDE LIGAND HAVING SPECIFIC AFFINITY FOR THE HIV1 RETROVIRUS p24 PROTEIN
10/21/1999WO1999053061A2 Tumor associated nucleic acids and uses therefor
10/21/1999WO1999053060A2 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999WO1999053058A1 Vertebrate patched-2 protein
10/21/1999WO1999053055A2 Therapeutic agent for ngf
10/21/1999WO1999053054A1 Axor4 g-protein-coupled receptor
10/21/1999WO1999053053A1 Gene coding for heliomicine and use thereof
10/21/1999WO1999053051A2 5' ests and encoded human proteins
10/21/1999WO1999053043A2 Herpes simplex virus latency associated transcript polypeptides
10/21/1999WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue
10/21/1999WO1999053038A2 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
10/21/1999WO1999053036A2 Ste20-related protein kinases
10/21/1999WO1999053035A1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells
10/21/1999WO1999053033A1 Methods and compositions for high yield production of eukaryotic proteins
10/21/1999WO1999053021A1 Cell differentiation/proliferation and maintenance factor and uses thereof
10/21/1999WO1999053020A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae
10/21/1999WO1999053019A1 Spores with altered resistance to sterilants
10/21/1999WO1999053018A2 Purification of cellular components that are substantially rna free
10/21/1999WO1999052947A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
10/21/1999WO1999052928A1 Transporter protein splice variants and model for immune diversity
10/21/1999WO1999052926A1 Regulated target expression for screening
10/21/1999WO1999052925A1 Programmed cell death and caspase-12
10/21/1999WO1999052511A1 Tarch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
10/21/1999WO1999046391A3 Prostate derived serine protease (pdsp) protein and nucleic acid molecules and uses therefor
10/21/1999WO1999046379A3 Human receptor proteins; related reagents and methods
10/21/1999WO1999042593A8 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/21/1999WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999WO1999040114A9 Novel gabab receptor dna sequences
10/21/1999WO1999038980A9 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
10/21/1999WO1999033870A3 Human regulatory proteins
10/21/1999WO1999015654A3 Tie receptor tyrosine kinase ligand homologues
10/21/1999WO1998041625A8 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
10/21/1999DE19818598A1 New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents
10/21/1999DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
10/21/1999DE19817921A1 New mycobacterial mutants used to screen for antibiotic vectors
10/21/1999DE19817557A1 Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe Human nucleic acid sequences from Ovartumorgewebe
10/21/1999DE19814853A1 Expressionssystem zur Produktion von Proteinen Expression system for production of proteins
10/21/1999DE19806581A1 Sequenzen eines Ih-Ionenkanals und deren Verwendung Sequences of Ih ion channel and their use
10/21/1999CA2369172A1 Ste20-related protein kinases
10/21/1999CA2328298A1 Method for electroelution of a biological sample and implementing device
10/21/1999CA2327519A1 Spores with altered resistance to sterilants
10/21/1999CA2327516A1 Programmed cell death and caspase-12
10/21/1999CA2325824A1 Tao protein kinases and methods of use therefor
10/21/1999CA2325662A1 Regulable gene expression in gram-positive bacteria
10/21/1999CA2325658A1 Gene coding for heliomicine and use thereof
10/21/1999CA2325602A1 Regulated target expression for screening
10/21/1999CA2325601A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells
10/21/1999CA2325599A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999CA2325598A1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells
10/21/1999CA2325575A1 Purification of cellular components that are substantially rna free
10/21/1999CA2325332A1 Therapeutic agent for ngf
10/21/1999CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999CA2325010A1 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999CA2324480A1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999CA2324364A1 Starch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
10/21/1999CA2319089A1 5' ests and encoded human proteins
10/20/1999EP0950717A1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
10/20/1999EP0950716A1 A product based on polysaccharides from bakers' yeast and its use as a technological coadjuvant for bakery products
10/20/1999EP0950712A1 Yeast vectors and process for producing proteins with the use of the same
10/20/1999EP0950108A1 Streptococcus pneumoniae dna sequences
10/20/1999EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999EP0950103A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/20/1999EP0950098A1 Stable expression of triple helical proteins
10/20/1999EP0950094A1 Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation
10/20/1999EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999EP0950089A1 Methods for the production of bacteria containing eukaryotic genes
10/20/1999EP0950028A1 Bioremediation of pollutants with butane-utilizing bacteria
10/20/1999EP0949930A1 Thermostable phosphatases
10/20/1999EP0949866A1 Plant immunization compositions
10/20/1999EP0553085B1 A high productivity, continuous fermentation process for carotenoid-producing microorganisms
10/20/1999CN1232507A Process for preparing fat oil contg. unsaturated fatty acid
10/20/1999CN1232503A Tumor necrosis factor related ligand
10/20/1999CN1232501A Modified TIE-2 -receptor ligands
10/20/1999CN1232499A Human growth gene and short stature gene region
10/20/1999CN1232497A AGE-1 polypeptides and related molecules and methods
10/20/1999CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999CN1232468A Acquired resistance NPR genes and uses thereof
10/20/1999CN1232467A Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
10/20/1999CN1232087A Polynucleotide molecules encoding neospora proteins
10/20/1999CN1231925A Method for breaking epispore of lucid ganoderma
10/19/1999US5969126 GNRH-leukotoxin chimeras